Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON and LONDON, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative...
-
Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform BOSTON and LONDON, Aug. 13, 2018 (GLOBE NEWSWIRE)...
-
BOSTON and LONDON, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through...
-
BOSTON and LONDON, July 09, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through...
-
BOSTON and LONDON, June 29, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through...
-
BOSTON and LONDON, June 07, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial stage biotech company dedicated to transforming the lives of patients with rare diseases through...
-
BOSTON and LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial stage company dedicated to transforming the lives of patients with rare diseases through innovative...
-
BOSTON and LONDON, April 24, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial and clinical-stage company dedicated to transforming the lives of patients with rare diseases through...
-
Agreement strengthens Orchard’s position as a global leader in gene therapy for rare diseasesGSK takes 19.9% equity stake in Orchard and seat on board LONDON, April 12, 2018 (GLOBE NEWSWIRE) -- ...